A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Trial to Evaluate the Duration of Action of Baclofen ER Capsules (GRS) in Subjects With Spasticity Due to Multiple Sclerosis (MS)
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 29 May 2017
At a glance
- Drugs Baclofen (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Sponsors Sun Pharma Advanced Research Company
- 23 May 2017 Planned End Date changed from 1 Jun 2017 to 1 Sep 2017.
- 23 May 2017 Status changed from recruiting to active, no longer recruiting.
- 08 Mar 2016 Planned End Date changed from 1 Dec 2015 to 1 Jun 2017, as reported by ClinicalTrials.gov record.